A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

The discovery of Epidermal Growth Factor Receptor (EGFR) mutations in Non Small Cell Lung Cancer (NSCLC) launched the era of personalized medicine in advanced NSCLC, leading to a dramatic shift in the therapeutic landscape of this disease. After ten years from the individuation of activating mutatio...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694955/
https://ncbi.nlm.nih.gov/pubmed/26308162
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items